BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23724906)

  • 1. Plasma progranulin levels in cortical dementia phenotypes with asymmetric perisylvian atrophy.
    Gómez-Tortosa E; Guerrero-López R; Gil-Neciga E; Franco E; del Ser T; Jiménez Escrig A; Pérez-Pérez J; Sainz MJ
    Eur J Neurol; 2013 Sep; 20(9):1319-24. PubMed ID: 23724906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort.
    Antonell A; Gil S; Sánchez-Valle R; Balasa M; Bosch B; Prat MC; Chiollaz AC; Fernández M; Yagüe J; Molinuevo JL; Lladó A
    J Alzheimers Dis; 2012; 31(3):581-91. PubMed ID: 22647257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mutation in the 5'-UTR of GRN gene associated with frontotemporal lobar degeneration: phenotypic variability and possible pathogenetic mechanisms.
    Puoti G; Lerza MC; Ferretti MG; Bugiani O; Tagliavini F; Rossi G
    J Alzheimers Dis; 2014; 42(3):939-47. PubMed ID: 25024321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia.
    van Swieten JC; Heutink P
    Lancet Neurol; 2008 Oct; 7(10):965-74. PubMed ID: 18771956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the variant Cys139Arg at GRN gene to the clinical spectrum of frontotemporal lobar degeneration.
    Piaceri I; Pradella S; Cupidi C; Nannucci S; Polito C; Bagnoli S; Tedde A; Smirne N; Anfossi M; Gallo M; Bernardi L; Colao R; Maletta R; Bruni AC; Sorbi S; Nacmias B
    J Alzheimers Dis; 2014; 40(3):679-85. PubMed ID: 24503614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members.
    Finch N; Baker M; Crook R; Swanson K; Kuntz K; Surtees R; Bisceglio G; Rovelet-Lecrux A; Boeve B; Petersen RC; Dickson DW; Younkin SG; Deramecourt V; Crook J; Graff-Radford NR; Rademakers R
    Brain; 2009 Mar; 132(Pt 3):583-91. PubMed ID: 19158106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain progranulin expression in GRN-associated frontotemporal lobar degeneration.
    Chen-Plotkin AS; Xiao J; Geser F; Martinez-Lage M; Grossman M; Unger T; Wood EM; Van Deerlin VM; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2010 Jan; 119(1):111-22. PubMed ID: 19649643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive white matter involvement in patients with frontotemporal lobar degeneration: think progranulin.
    Caroppo P; Le Ber I; Camuzat A; Clot F; Naccache L; Lamari F; De Septenville A; Bertrand A; Belliard S; Hannequin D; Colliot O; Brice A
    JAMA Neurol; 2014 Dec; 71(12):1562-6. PubMed ID: 25317628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration.
    Ghidoni R; Benussi L; Glionna M; Franzoni M; Binetti G
    Neurology; 2008 Oct; 71(16):1235-9. PubMed ID: 18768919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel progranulin mutation causing frontotemporal lobar degeneration with heterogeneous phenotypic expression.
    Rossi G; Piccoli E; Benussi L; Caso F; Redaelli V; Magnani G; Binetti G; Ghidoni R; Perani D; Giaccone G; Tagliavini F
    J Alzheimers Dis; 2011; 23(1):7-12. PubMed ID: 20930271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Losing protein in the brain: the case of progranulin.
    Ghidoni R; Paterlini A; Albertini V; Binetti G; Benussi L
    Brain Res; 2012 Oct; 1476():172-82. PubMed ID: 22348647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel progranulin mutations with reduced serum-progranulin levels in frontotemporal lobar degeneration.
    Chiang HH; Forsell C; Lilius L; Öijerstedt L; Thordardottir S; Shanmugarajan K; Westerlund M; Nennesmo I; Thonberg H; Graff C
    Eur J Hum Genet; 2013 Nov; 21(11):1260-5. PubMed ID: 23463024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory molecules in Frontotemporal Dementia: cerebrospinal fluid signature of progranulin mutation carriers.
    Galimberti D; Bonsi R; Fenoglio C; Serpente M; Cioffi SM; Fumagalli G; Arighi A; Ghezzi L; Arcaro M; Mercurio M; Rotondo E; Scarpini E
    Brain Behav Immun; 2015 Oct; 49():182-7. PubMed ID: 26021560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel frameshift GRN mutation results in frontotemporal lobar degeneration with a distinct clinical phenotype in two siblings: case report and literature review.
    Hosaka T; Ishii K; Miura T; Mezaki N; Kasuga K; Ikeuchi T; Tamaoka A
    BMC Neurol; 2017 Sep; 17(1):182. PubMed ID: 28915852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Splice-Acceptor Site Mutation in GRN (c.709-2 A>T) Causes Frontotemporal Dementia Spectrum in a Large Family from Southern Italy.
    Sassi C; Capozzo R; Gibbs R; Crews C; Zecca C; Arcuti S; Copetti M; Barulli MR; Brescia V; Singleton AB; Logroscino G
    J Alzheimers Dis; 2016 May; 53(2):475-85. PubMed ID: 27258413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation.
    Papegaey A; Eddarkaoui S; Deramecourt V; Fernandez-Gomez FJ; Pantano P; Obriot H; Machala C; Anquetil V; Camuzat A; Brice A; Maurage CA; Le Ber I; Duyckaerts C; Buée L; Sergeant N; Buée-Scherrer V
    Acta Neuropathol Commun; 2016 Jul; 4(1):74. PubMed ID: 27435172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretory leukocyte protease inhibitor protein regulates the penetrance of frontotemporal lobar degeneration in progranulin mutation carriers.
    Ghidoni R; Flocco R; Paterlini A; Glionna M; Caruana L; Tonoli E; Binetti G; Benussi L
    J Alzheimers Dis; 2014; 38(3):533-9. PubMed ID: 24018267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series.
    Beck J; Rohrer JD; Campbell T; Isaacs A; Morrison KE; Goodall EF; Warrington EK; Stevens J; Revesz T; Holton J; Al-Sarraj S; King A; Scahill R; Warren JD; Fox NC; Rossor MN; Collinge J; Mead S
    Brain; 2008 Mar; 131(Pt 3):706-20. PubMed ID: 18234697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid biomarkers in Progranulin mutations carriers.
    Carecchio M; Fenoglio C; Cortini F; Comi C; Benussi L; Ghidoni R; Borroni B; De Riz M; Serpente M; Cantoni C; Franceschi M; Albertini V; Monaco F; Rainero I; Binetti G; Padovani A; Bresolin N; Scarpini E; Galimberti D
    J Alzheimers Dis; 2011; 27(4):781-90. PubMed ID: 21891865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia.
    Mukherjee O; Wang J; Gitcho M; Chakraverty S; Taylor-Reinwald L; Shears S; Kauwe JS; Norton J; Levitch D; Bigio EH; Hatanpaa KJ; White CL; Morris JC; Cairns NJ; Goate A
    Hum Mutat; 2008 Apr; 29(4):512-21. PubMed ID: 18183624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.